Condition: Chronic Heart Failure · Iron Deficiency, Latent · Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences
Observational cohort randomized controlled study to study the influence of correction of ID by intravenous injection of ferric carboxymaltose (Ferinject®) on quality of life indicators, functional status in a cohort of patients with HFpEF.
This description comes directly from the study's public registry record.
Olga V. Tukish, Ph.D. · +79069476343 · olgatukish@yandex.ru
Always discuss trial participation with your own doctor first.
| Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences | Tomsk, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05793996